ADJUNCTIVE ATYPICAL ANTIPSYCHOTIC (AAP) CHOICE AFFECTS HEALTHCARE UTILIZATION IN MAJOR DEPRESSIVE DISORDER (MDD)

被引：0
|
作者：
Broder, M. S. [1 ]
Greene, M. [2 ]
Yan, T. [1 ]
Chang, E. [1 ]
Hartry, A. [3 ]
Yermilov, I [1 ]
Duffy, R. [2 ]
机构：
[1] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[2] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[3] Lundbeck, Deerfield, IL USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.587
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH31
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [1] Healthcare resource utilization with adjunctive cariprazine and other atypical antipsychotics in patients with major depressive disorder
    Clayton, Anita H.
    Parikh, Mousam
    Yee, Tracy
    Mercer, Daniel
    Sun, Haiyan
    Cummings, Nicholas
    Rava, Andrew
    Hayes, Oscar
    Nabulsi, Nadia
    CURRENT MEDICAL RESEARCH AND OPINION, 2025, 41 (02) : 219 - 226
  • [2] HEALTHCARE RESOURCE UTILIZATION WITH ADJUNCTIVE CARIPRAZINE AND OTHER ATYPICAL ANTIPSYCHOTICS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Clayton, A. H.
    Yee, T.
    Sun, H.
    Cummings, N.
    Hayes, O. A.
    Nabulsi, N.
    Parikh, M.
    VALUE IN HEALTH, 2023, 26 (06) : S104 - S104
  • [3] Healthcare resource utilization with adjunctive cariprazine and other atypical antipsychotics in patients with major depressive disorder
    Clayton, Anita H.
    Parikh, Mousam
    Yee, Tracy
    Mercer, Daniel
    Sun, Haiyan
    Cummings, Nicholas
    Rava, Andrew
    Hayes, Oscar
    Nabulsi, Nadia
    CURRENT MEDICAL RESEARCH AND OPINION, 2025,
  • [4] Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment
    Broder, Michael S.
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Yermilov, Irina
    CLINICAL THERAPEUTICS, 2019, 41 (02) : 221 - 232
  • [5] COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Taneja, C.
    Oster, G.
    Jing, Y.
    Baker, R. A.
    Forbes, R. A.
    Papakostas, G., I
    VALUE IN HEALTH, 2010, 13 (03) : A113 - A113
  • [6] CHANGE IN HEALTHCARE UTILIZATION AND COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) INITIATING ADJUNCTIVE THERAPY WITH SECOND-GENERATION ANTIPSYCHOTICS (SGAS)
    Hagiwara, M.
    Sun, S. X.
    Moynahan, A.
    Bornheimer, R.
    Oster, G.
    VALUE IN HEALTH, 2015, 18 (03) : A119 - A119
  • [7] Adjunctive aripiprazole in major depressive disorder (MDD): efficacy and predictors of remission
    Nelson, J. C.
    Thase, M. E.
    Baker, R. A.
    Rollin, L. M.
    McQuade, R. D.
    Marcus, R. N.
    Berman, R. M.
    Wisniewski, S. R.
    Gismondi, R.
    Loze, J. Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S386 - S386
  • [8] Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder
    Seetasith, Arpamas
    Greene, Mallik
    Hartry, Ann
    Burudpakdee, Chakkarin
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (09) : 888 - 901
  • [9] Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder
    Yan, Tingjian
    Greene, Mallik
    Chang, Eunice
    Houle, Christy R.
    Tarbox, Marian H.
    Broder, Michael S.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 81 - 89
  • [10] The effects of antidepressant monotherapy versus adjunctive therapy with an atypical antipsychotic in new-onset major depressive disorder
    Baek, Daeup
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2012, 16 : 16 - 16
12345